JOBSEEKERS
Login
Sign Up
Jobseeker
Employer
Staffing Firm
Direct Client
Business Development Consultancy interview questions
Business Development Consultancy interview questions
Back
Take as many assements as you can to improve your validate your skill rating
Total Questions: 5
1. On what will the financial terms of the deal be based?
A. It will be based on the value assigned to the asset and decisions about how that value is to be shared.
B. It will be based upon the total value of the companies entering into the negotiations.
C. It will be based on the value that each party brings to the deal.
D. The FDA must assign the value of the product in question.
Show Correct Answer
Correct Answer is :
It will be based on the value assigned to the asset and decisions about how that value is to be shared.
2. What type of product has high risk and low value in a deal?
A. A product that has FDA approval
B. A late stage product
C. An early stage product
D. A product that is undergoing off-label investigator trials
Show Correct Answer
Correct Answer is :
An early stage product
3. What is the most common way BD mitigates risk in deals?
A. By working with the legal team to product airtight contracts that absolves them of any risk.
B. Through the careful structuring of deal payments.
C. By only entering into negotiations regarding late stage compounds.
D. By employing Steve Jaben to handle their legal affairs.
Show Correct Answer
Correct Answer is :
Through the careful structuring of deal payments.
4. What are milestone payments?
A. Reoccurring payments that happen in predefined intervals.
B. Payments that are based on sales performance.
C. Where one party leaves bags of money at certain milemarkers along the interstate.
D. Payments that are contingent on the achievement of certain development or commercialization goals.
Show Correct Answer
Correct Answer is :
Payments that are contingent on the achievement of certain development or commercialization goals.
5. What type of deal would require FDA/external regulatory body approval?
A. When the joint venture would create antitrust concerns through less competition in the market.
B. The FDA must always approve BD deals between companies.
C. In cases where the contract calls for a change in manufacturing facilities.
D. None. Approval is received from internal regulatory bodies only.
Show Correct Answer
Correct Answer is :
In cases where the contract calls for a change in manufacturing facilities.
Similar Interview Questions
Search for latest jobs
Find Jobs